News - Magnitude Biosciences

Skip to content

VivoScan™ Platform
WormGazer™ Technology
Our Assays
Company
Resources
- All Resources
- FAQ
- Case Studies
- Videos
- Publications
- Brochures
News
Contact

Search for:

VivoScan™ Platform
WormGazer™ Technology
Our Assays
Company
Resources
- All Resources
- FAQ
- Case Studies
- Videos
- Publications
- Brochures
News
Contact

The latest from
Magnitude Biosciences

Follow what we’ve been up to along the way

magnitude just text (1)

Magnitude Biosciences and BioAscent Discovery Announce Collaboration to Profile Chemogenomics Library Using VivoScan™ Whole-Organism Screening

Magnitude Biosciences secures over £700,000 to accelerate in vivo high-throughput drug discovery platform

Publication: New tools to monitor Pseudomonas aeruginosa infection and biofilms in vivo in C. elegans

Publication: Timut Pepper Extract Slows Age-Dependent Decline of Mobility and Collagen Loss and Promotes Longevity

Magnitude Biosciences: Revolutionising Research

Publication: Rapid measurement of ageing by automated monitoring of movement of C. elegans populations

Life Sciences consortium celebrate collective multi-million Biomedical Catalyst 2023 Innovate UK grant

Magnitude Biosciences awarded grant to accelerate the identification of compounds that could slow ageing or treat age-related diseases

AB Biotek works with Magnitude Biosciences to accelerate probiotic development

Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease

Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services

Magnitude Biosciences Appoints New CEO Fozia Saleem to Drive Growth

SMER28 Extends Healthspan – Revealing a New Target for Ageing Therapeutics

Magnitude Biosciences CEO David Weinkove appointed new Chair of British Society for Research on Ageing

Magnitude Biosciences, Perfectus Biomed Group and University of Kent Project Funded by National Biofilms Innovation Centre for Tackling and Exploiting Biofilms

Research on ageing leader Magnitude Biosciences expands its project delivery team to meet increased demand

Magnitude Biosciences recognised in ‘Developed in Durham’ as local success story

Magnitude Biosciences to attend Translating Ideas Into Therapies 2021 and the International C. elegans Conference in June 2021

The worm angle on the taurine story: A route to the clinic by understanding mechanism

Magnitude Biosciences secures its second round of funding to support its pre-clinical research services

Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, Paris

Magnitude Biosciences announces new hires to support continued growth

Magnitude Biosciences secures UK government Future Fund to expand its workforce

Magnitude Biosciences’ new COVID-19 compatible laboratory is fully operational and ready to support research

Our Services

Ageing & Longevity
Microbiome
Neurodegeneration
Toxicity
Transgenics

Who we help

Nutraceuticals & Ingredients
Cosmeceuticals
Biotechnology
Pharma
Academia

Why C. elegans?

WormGazer™ Technology
VivoScan™ Platform

News
Resources
Contact

Company

About Us
Our Team
Testimonials
Jobs

Legal

Privacy
Cookies

© 2025 Magnitude Biosciences Ltd.
Registered in England and Wales under Company Number 11579884. All rights reserved.

Scroll to Top